Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Accumulated Expenses: 2018-2024

Historic Other Accumulated Expenses for Whitehawk Therapeutics (WHWK) over the last 5 years, with Dec 2024 value amounting to $650,000.

  • Whitehawk Therapeutics' Other Accumulated Expenses was N/A to $105,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $105,000, marking a year-over-year change of. This contributed to the annual value of $650,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Other Accumulated Expenses is $650,000, which was up 31.05% from $496,000 recorded in FY2021.
  • In the past 5 years, Whitehawk Therapeutics' Other Accumulated Expenses ranged from a high of $650,000 in FY2024 and a low of $173,000 during FY2020.
  • In the last 1 years, Whitehawk Therapeutics' Other Accumulated Expenses had a median value of $650,000 in 2024 and averaged $650,000.
  • Data for Whitehawk Therapeutics' Other Accumulated Expenses shows a peak YoY soared of 1,185.00% (in 2020) over the last 5 years.
  • Over the past 3 years, Whitehawk Therapeutics' Other Accumulated Expenses (Yearly) stood at $173,000 in 2020, then surged by 186.71% to $496,000 in 2021, then reached $650,000 in 2024.